Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, is available as both an injection and a tablet form. Clinical trials show both delivery methods produce meaningful weight loss when combined with lifestyle changes, but they differ in convenience, absorption, and dosing schedules. Choosing between them depends on your personal preferences, medical history, and treatment goals.
What Is Semaglutide and How Does It Work
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist—a medication that mimics a natural hormone your body produces to regulate blood sugar and appetite. When semaglutide binds to GLP-1 receptors in your brain, it signals fullness, slows stomach emptying, and reduces hunger cravings. This multi-pathway effect makes it effective for weight management in people with obesity or overweight conditions.
The medication works on both hunger centers and metabolic pathways, which is why patients often report reduced food cravings within days of starting treatment. Research published in major medical journals has demonstrated consistent weight loss of 15–22% of baseline body weight over 68 weeks in clinical trials. Both injectable and oral forms deliver semaglutide to your system, but the route and timing differ significantly.
Injectable Semaglutide: Convenience and Consistency
Injectable semaglutide is administered once per week as a subcutaneous injection—a needle-and-pen combination similar to insulin pens used by diabetics. The weekly schedule reduces dosing burden compared to daily oral medications, and the injection delivers semaglutide directly into subcutaneous tissue, where it is absorbed steadily over seven days. Many patients find this rhythm easier to remember than daily pill-taking routines.
Injection-based therapy typically produces more predictable blood levels because the medication bypasses first-pass liver metabolism entirely. This direct absorption pathway may explain why some patients report faster initial appetite suppression with injections. Weekly dosing also means fewer opportunities to miss doses, which supports better long-term adherence and weight loss outcomes in real-world practice.
Oral Semaglutide Tablets: Daily Dosing Flexibility
Oral semaglutide tablets are taken once daily on an empty stomach, typically 30 minutes before breakfast. The oral form requires specific administration instructions—you must wait at least 30 minutes after taking the tablet before consuming food or other medications—because semaglutide is absorbed in the stomach and upper intestine. This timing sensitivity demands more attention than weekly injections but offers greater flexibility for patients who prefer not to self-inject.
Oral semaglutide absorption is lower than injectable forms because some medication is broken down by stomach acid and digestive enzymes before reaching the bloodstream. Despite lower bioavailability, clinical trials confirm that oral semaglutide produces significant weight loss when dosed appropriately, typically reaching therapeutic levels after 4–8 weeks of consistent daily use. Daily dosing allows for micro-adjustments if side effects emerge, and some patients find pill-taking less intimidating than injections.
Comparing Efficacy, Side Effects, and Personal Fit
Both injection and oral semaglutide produce comparable weight loss outcomes in clinical practice when patients remain adherent and achieve therapeutic doses. Head-to-head trials show that weekly injections may produce slightly faster initial results due to higher peak concentrations, but oral formulations catch up within 8–12 weeks. The choice between them should prioritize your ability to stick with the regimen consistently, as adherence matters more than the marginal difference in efficacy.
Common side effects—nausea, vomiting, constipation, and reduced appetite—occur with both forms and are usually mild to moderate during the first 2–4 weeks. Injection users report fewer gastrointestinal complaints because the medication avoids direct stomach contact, while oral users occasionally experience reflux or stomach discomfort if timing guidelines are not followed precisely. PlexusDx offers both compounded semaglutide injection and oral tablet options from licensed 503A pharmacies, allowing you to select the delivery method that aligns with your lifestyle and medical needs.
PlexusDx Personalized Semaglutide Therapy Options
PlexusDx provides access to compounded semaglutide in both injectable and oral forms from licensed 503A compounding pharmacies, with flat monthly pricing that does not change as your dose increases. Compounded medications allow for customized strengths and flexible dosing schedules tailored to your body's needs and response. PlexusDx serves all 50 states without insurance requirements, and both semaglutide formulations are HSA/FSA eligible.
For patients seeking precision-guided therapy, PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that evaluates key variants like GLP1R rs6923761 and FTO rs9939609 to identify how your body processes appetite-regulating peptides. This test maps 14 biological pathways and 150+ genetic insights, helping your provider optimize your semaglutide dose and predict which delivery form may work best for your genetic profile. Combined with monthly telehealth support, PlexusDx helps you achieve sustained weight loss by matching therapy to your individual physiology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Wegovy a pill or a shot?
Wegovy—the brand-name semaglutide—comes as a weekly injection. However, semaglutide is also available in oral tablet form through compounding pharmacies like those used by PlexusDx. Both contain the same active ingredient but differ in delivery method and dosing schedule.
Which form of semaglutide causes fewer side effects?
Injectable semaglutide typically produces fewer nausea and gastrointestinal complaints because it avoids direct stomach contact. Oral semaglutide may cause more stomach-related side effects if timing or food intake guidelines are not followed correctly. Individual responses vary, and most side effects resolve within 2–4 weeks regardless of form.
Can I switch between injection and oral semaglutide during treatment?
Yes, many patients switch between forms based on lifestyle changes or side effect tolerance. Your PlexusDx provider can help you transition safely and adjust your dose accordingly, since oral formulations typically require higher nominal doses to match injection effectiveness due to lower absorption.
How much does oral semaglutide cost at PlexusDx?
PlexusDx offers compounded oral semaglutide starting at $249 per month with flat monthly pricing—your dose may need to go up, but your price won't. Both oral and injectable semaglutide are HSA/FSA eligible, and PlexusDx serves all 50 states without insurance or membership fees.
Does PlexusDx offer genetic testing to choose between injection and oral?
Yes. PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, FTO, MC4R, and GIPR genes to predict how your body will respond to semaglutide therapy. This test maps 14 pathways and 150+ genetic insights, helping your provider select the optimal delivery form and dose for your unique peptide metabolism.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic Injection Timing: Morning, Night, or What Works Best for You?
Navigating Weight Loss with Wegovy: Can You Take It If You Have No Gallbladder?